Hannah Brendan Insider Trades

Insider Trading History

Track insider trading activity for Hannah Brendan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quince Therapeutics
Quince Therapeutics QNCX
Cbo, COO & CCO
Holding Value $402k 365,000 shares
Last Trade
Jan 23, 2026 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 365,000 shares
$3.08
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Cbo, COO & CCO
Holding Value $398k 361,827 shares
Last Trade
Dec 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$110k 27,551 shares
$4.01
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Cbo, COO & CCO
Holding Value $220k 199,720 shares
Last Trade
Dec 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$110k 27,551 shares
$4.01
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Cbo, COO & CCO
Holding Value $368k 334,276 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.3k 37,736 shares
$1.36
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Cbo, COO And CCO
Holding Value $495k 450,000 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 450,000 shares
$1.60
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $326k 296,540 shares
Last Trade
Aug 21, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.4k 30,845 shares
$0.63
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $292k 265,695 shares
Last Trade
Aug 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.55k 5,924 shares
$0.60
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $286k 259,771 shares
Last Trade
Aug 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.25k 2,155 shares
$0.58
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $52.2k 47,439 shares
Last Trade
Jun 04, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$50.5k 56,061 shares
$0.90
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $283k 257,616 shares
Last Trade
Jun 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$50.5k 56,061 shares
$0.90
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
CHIEF BUSINESS OFFICER AND COO
Holding Value $660k 600,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$786k 600,000 shares
$1.31
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Chief Business Officer And COO
Holding Value $82.5k 75,000 shares
Last Trade
Oct 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.3k 75,000 shares
$0.99
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Chief Business Officer
Holding Value $222k 201,555 shares
Last Trade
Aug 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87.5k 71,762 shares
$1.22
$1.10
Quince Therapeutics
Quince Therapeutics QNCX
Chief Business Officer
Holding Value $248k 225,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 225,000 shares
$0.94
$1.10
Cortexyme
Cortexyme CRTX
Chief Business Officer
Holding Value $690k 353,656 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 353,656 shares
$3.30
$1.95
Cortexyme
Cortexyme CRTX
Chief Business Officer
Holding Value $253k 129,793 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 113,569 shares
$3.30
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up